COVID-19 and pulmonary alveolar proteinosis: an unusual combination
Open Access
- 17 December 2022
- journal article
- letter
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 49 (1) , e20220330
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre studyERJ Open Research, 2022
- Autoimmune Pulmonary Alveolar ProteinosisAmerican Journal of Respiratory and Critical Care Medicine, 2022
- COVID-19 in LymphangioleiomyomatosisChest, 2021
- Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide studyEuropean Respiratory Journal, 2021
- Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter StudyAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Targeting GM-CSF in COVID-19 Pneumonia: Rationale and StrategiesFrontiers in Immunology, 2020
- Inhaled GM-CSF for Pulmonary Alveolar ProteinosisNew England Journal of Medicine, 2019
- Pulmonary alveolar proteinosisNature Reviews Disease Primers, 2019